All News

Top news of the day from across the health care landscape.

The FDA has released a warning on cases of rare, serious genital area infections having been reported with sodium-glucose contransporter-2 (SGLT2) inhibitors.

FDA officials are requiring a warning about this on the prescription information.

One lot of CVS Health 12 Hour Sinus Relief Nasal Mist has been voluntarily recalled. Product Quest Manufacturing expanded the recall to include other products made at the same facility.

A new study has found that fibromyalgia exacerbates depressive symptoms, migraine intensity, and migraine-related disability.

The pet products included in the recall—sold to both consumers and veterinary professionals—are marketed for a variety of uses, including urinary incontinence, anxiety, arthritis, and digestion relief.

The evolution of specialty pharmacy has raised the stakes for the services that patients expect during treatment.

A synthetic chemical caused the self-destruction of glioblastoma tumor cells transferred from human patients into mice.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Study shows the safety and efficacy of treatment with sofosbuvir and velpatasvir in adults with recurrent chronic genotypes 1-4 HCV infection after liver transplant.

The study's findings show that patients with HIV will forgo short travel distances and wait times in order to access a health care provider with a positive attitude.

Recent data show that more adolescents are starting and completing the series of HPV vaccinations meant to prevent cervical cancer. Despite the incease in immunizations, some forms of cancers caused by HPV are rising.

Researchers investigated whether heavy alcohol consumption in early life was associated with high-grade prostate cancer in adulthood.

Top news of the day from across the health care landscape.

Daily aspirin did not reduce the occurrence of major cardiovascular events a study of more than 12,500 participants considered to be at risk, according to the results of the ARRIVE trial.

Eravacycline is a tetracycline-class antibacterial injection that has demonstrated potent activity against multidrug-resistant pathogens.

Women who carry the BRCA1 and BRCA2 gene mutations are at an increased risk of breast and ovarian cancer, yet many women are unaware of their mutation status.

Top news of the day from across the health care landscape

Amyotrophic lateral sclerosis and frontotemporal dementia exhibit key similarities in underlying molecular mechanisms tied to the dysfunction of RNA-binding proteins.

Officials with the FDA have approved eravacycline (XERAVA, Tetraphase Pharmaceuticals), a fluorocycline antibacterial within the tetracycline class of antibacterial drugs, for the treatment of complicated intra-abdominal infections (cIAI) in patients aged 18 years and older.

Everything you need to know about WCH from diagnosis, treatment, and a review of the literature.

Have a recruiting and hiring strategy that is unmistakably the best.

One lot of Children’s Advil® Suspension, Bubble Gum Flavored Liquid bottles (4 fluid ounces) is being voluntarily recalled by Pfizer Consumer Healthcare

Accord Healthcare Inc. is voluntarily recalling 1 lot of Hydrochlorothiazide Tablets USP, 12.5 mg, at the consumer level, due to a potential labeling mix-up.

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

Daily aspirin did not reduce the occurrence of major cardiovascular events a study of more than 12,500 participants considered to be at risk.

Substituting brand name combination drugs for lower-cost generics could have reduced spending by $925 million in 2016.

New drug could serve as a potential treatment option for patients who have shown an inadequate response to conventional disease-modifying drugs.